H B Fuller vs Element Solutions: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

H B Fuller Company (FUL)

Q3 202624 Jun – 6 Sep 2026

▲2

Fuller's profit beat and buyout battle reshape its path

Strong Q2 earnings and raised guidance Fuller's second-quarter profit rose 19% to $1.41 per share, revenue grew 5.8%, and the company raised its full-year profit outlook. This shows the core business is performing well, which supports a higher stock price.
This is the main positive fundamental driver for FUL's price this period.
Acquisition of Advanced Medical Solutions Fuller agreed to buy Advanced Medical Solutions for £715 million, moving into higher-growth medical adhesives. The deal should boost long-term growth but will temporarily raise debt to about 4 times earnings, and an activist investor opposes it.
This is a major strategic move that affects FUL's growth and risk profile.
Ancora's buyout offer for building adhesives unit Ancora offered $1.1–1.2 billion for Fuller's Building Adhesives Solutions unit, but the board rejected it as too low. The offer highlights the unit's value and could pressure management to unlock it, potentially lifting the stock.
This event shows external interest in Fuller's assets and could lead to value creation.

July 202624 Jun – 6 Sep 2026

▲2

Fuller's profit beat and buyout battle reshape its path

Strong Q2 earnings and raised guidance Fuller's second-quarter profit rose 19% to $1.41 per share, revenue grew 5.8%, and the company raised its full-year profit outlook. This shows the core business is performing well, which supports a higher stock price.
This is the main positive fundamental driver for FUL's price this period.
Acquisition of Advanced Medical Solutions Fuller agreed to buy Advanced Medical Solutions for £715 million, moving into higher-growth medical adhesives. The deal should boost long-term growth but will temporarily raise debt to about 4 times earnings, and an activist investor opposes it.
This is a major strategic move that affects FUL's growth and risk profile.
Ancora's buyout offer for building adhesives unit Ancora offered $1.1–1.2 billion for Fuller's Building Adhesives Solutions unit, but the board rejected it as too low. The offer highlights the unit's value and could pressure management to unlock it, potentially lifting the stock.
This event shows external interest in Fuller's assets and could lead to value creation.

Latest24 Jun – 6 Sep 2026

▲2

Fuller's profit beat and buyout battle reshape its path

Strong Q2 earnings and raised guidance Fuller's second-quarter profit rose 19% to $1.41 per share, revenue grew 5.8%, and the company raised its full-year profit outlook. This shows the core business is performing well, which supports a higher stock price.
This is the main positive fundamental driver for FUL's price this period.
Acquisition of Advanced Medical Solutions Fuller agreed to buy Advanced Medical Solutions for £715 million, moving into higher-growth medical adhesives. The deal should boost long-term growth but will temporarily raise debt to about 4 times earnings, and an activist investor opposes it.
This is a major strategic move that affects FUL's growth and risk profile.
Ancora's buyout offer for building adhesives unit Ancora offered $1.1–1.2 billion for Fuller's Building Adhesives Solutions unit, but the board rejected it as too low. The offer highlights the unit's value and could pressure management to unlock it, potentially lifting the stock.
This event shows external interest in Fuller's assets and could lead to value creation.

Element Solutions Inc (ESI)

Q3 20266 Jul – 31 Jul 2026

▲4

Solstice's $14.5B buyout and record Q2 results drive ESI

Solstice to acquire ESI at a 15% premium Solstice Advanced Materials agreed to buy Element Solutions for $14.5 billion, or about $50.10 per share, a 15% premium. ESI holders get $10 cash plus 0.5 Solstice shares per share. This locks in a higher value for ESI and supports the stock price.
The acquisition is the main event setting a floor and premium for ESI shares.
Record Q2 sales and raised 2026 profit outlook ESI reported record Q2 net sales of $977.9 million, up 56%, with profit rising to $77.3 million. Electronics revenue jumped 75% on AI data center and semiconductor demand. Management raised full-year 2026 adjusted EBITDA guidance to $690–710 million, signaling confidence.
Strong results and higher guidance show the business is performing well, supporting the stock.
Q2 earnings beat estimates, stock up 49.8% YTD ESI beat Q2 earnings and revenue estimates, with adjusted EPS of $0.47 versus $0.43 expected. Revenue topped consensus by 11.5%. The company has now beaten estimates for four straight quarters. Shares have gained about 49.8% this year, far outpacing the S&P 500.
Consistent beats and strong stock performance reinforce positive momentum.
Solstice raises 2026 guidance, cites ESI deal Solstice, the buyer, reported strong Q2 sales of $1.15 billion and raised its full-year 2026 outlook. Its CEO highlighted the pending ESI acquisition as key to building an advanced materials platform with more electronics and AI exposure. A healthier buyer reduces deal risk.
A financially strong acquirer makes the pending merger more likely to close smoothly.

July 20266 Jul – 31 Jul 2026

▲4

Solstice's $14.5B buyout and record Q2 results drive ESI

Solstice to acquire ESI at a 15% premium Solstice Advanced Materials agreed to buy Element Solutions for $14.5 billion, or about $50.10 per share, a 15% premium. ESI holders get $10 cash plus 0.5 Solstice shares per share. This locks in a higher value for ESI and supports the stock price.
The acquisition is the main event setting a floor and premium for ESI shares.
Record Q2 sales and raised 2026 profit outlook ESI reported record Q2 net sales of $977.9 million, up 56%, with profit rising to $77.3 million. Electronics revenue jumped 75% on AI data center and semiconductor demand. Management raised full-year 2026 adjusted EBITDA guidance to $690–710 million, signaling confidence.
Strong results and higher guidance show the business is performing well, supporting the stock.
Q2 earnings beat estimates, stock up 49.8% YTD ESI beat Q2 earnings and revenue estimates, with adjusted EPS of $0.47 versus $0.43 expected. Revenue topped consensus by 11.5%. The company has now beaten estimates for four straight quarters. Shares have gained about 49.8% this year, far outpacing the S&P 500.
Consistent beats and strong stock performance reinforce positive momentum.
Solstice raises 2026 guidance, cites ESI deal Solstice, the buyer, reported strong Q2 sales of $1.15 billion and raised its full-year 2026 outlook. Its CEO highlighted the pending ESI acquisition as key to building an advanced materials platform with more electronics and AI exposure. A healthier buyer reduces deal risk.
A financially strong acquirer makes the pending merger more likely to close smoothly.

Latest6 Jul – 31 Jul 2026

▲4

Solstice's $14.5B buyout and record Q2 results drive ESI

Solstice to acquire ESI at a 15% premium Solstice Advanced Materials agreed to buy Element Solutions for $14.5 billion, or about $50.10 per share, a 15% premium. ESI holders get $10 cash plus 0.5 Solstice shares per share. This locks in a higher value for ESI and supports the stock price.
The acquisition is the main event setting a floor and premium for ESI shares.
Record Q2 sales and raised 2026 profit outlook ESI reported record Q2 net sales of $977.9 million, up 56%, with profit rising to $77.3 million. Electronics revenue jumped 75% on AI data center and semiconductor demand. Management raised full-year 2026 adjusted EBITDA guidance to $690–710 million, signaling confidence.
Strong results and higher guidance show the business is performing well, supporting the stock.
Q2 earnings beat estimates, stock up 49.8% YTD ESI beat Q2 earnings and revenue estimates, with adjusted EPS of $0.47 versus $0.43 expected. Revenue topped consensus by 11.5%. The company has now beaten estimates for four straight quarters. Shares have gained about 49.8% this year, far outpacing the S&P 500.
Consistent beats and strong stock performance reinforce positive momentum.
Solstice raises 2026 guidance, cites ESI deal Solstice, the buyer, reported strong Q2 sales of $1.15 billion and raised its full-year 2026 outlook. Its CEO highlighted the pending ESI acquisition as key to building an advanced materials platform with more electronics and AI exposure. A healthier buyer reduces deal risk.
A financially strong acquirer makes the pending merger more likely to close smoothly.